Abbott Sues Roche, Bayer Over Glucose Diagnostics Patents
Filed in U.S. District Court for the Northern District of California, the suits target big players in the massive diagnostics and pharmaceutical industries. Technology for testing glucose levels in diabetics creates significant revenue for the defendants, a subsidiary of Germany-based Bayer and a division of Switzerland-based F. Hoffmann-La Roche Ltd.
The first of two patents refers...
To view the full article, register now.